Works matching IS 03125963 AND DT 2022 AND VI 61 AND IP 8
Results: 10
Clinical Pharmacokinetics of Metoprolol: A Systematic Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 8, p. 1187, doi. 10.1007/s40262-022-01141-2
- By:
- Publication type:
- Article
Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance Estimation.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 8, p. 1157, doi. 10.1007/s40262-022-01138-x
- By:
- Publication type:
- Article
Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 8, p. 1177, doi. 10.1007/s40262-022-01133-2
- By:
- Publication type:
- Article
Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 8, p. 1167, doi. 10.1007/s40262-022-01130-5
- By:
- Publication type:
- Article
Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prediction of Drug-Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 8, p. 1143, doi. 10.1007/s40262-022-01126-1
- By:
- Publication type:
- Article